{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:05:30Z","timestamp":1789142730818,"version":"build-2803163510"},"reference-count":36,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2016,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:label\/>\n                    <jats:p>\n                      Central serous chorioretinopathy (\n                      <jats:styled-content style=\"fixed-case\">CSCR<\/jats:styled-content>\n                      ) is a common retinal cause of visual loss. The mainstays of management are observation, photodynamic therapy (\n                      <jats:styled-content style=\"fixed-case\">PDT<\/jats:styled-content>\n                      ) and laser procedures. Over the past decade, there has been rapid development in the existing and novel imaging techniques, functional testing and management of\n                      <jats:styled-content style=\"fixed-case\">CSCR<\/jats:styled-content>\n                      . However, there is no convincing treatment designed for\n                      <jats:styled-content style=\"fixed-case\">CSCR<\/jats:styled-content>\n                      yet. In recent years, the advances in\n                      <jats:styled-content style=\"fixed-case\">PDT<\/jats:styled-content>\n                      , with various adjustments in fluence and verteporfin dosage, and the comparisons between different types of\n                      <jats:styled-content style=\"fixed-case\">PDT<\/jats:styled-content>\n                      for acute and chronic\n                      <jats:styled-content style=\"fixed-case\">CSCR<\/jats:styled-content>\n                      in recent studies have provided greater insights into the role of\n                      <jats:styled-content style=\"fixed-case\">PDT<\/jats:styled-content>\n                      in treating\n                      <jats:styled-content style=\"fixed-case\">CSCR<\/jats:styled-content>\n                      . Novel laser procedures, such as the diode micropulse laser, have shown comparable efficacy to conventional lasers without laser\u2010induced damage. Antivascular endothelial growth factor, which was originally developed for treating cancers, has emerged to be a potentially effective treatment for\n                      <jats:styled-content style=\"fixed-case\">CSCR<\/jats:styled-content>\n                      . The potential role of mineralocorticoid receptor antagonists in treating\n                      <jats:styled-content style=\"fixed-case\">CSCR<\/jats:styled-content>\n                      has provided greater understanding of the pathogenesis. Based on the relevant studies, mainly from the past decade, we discuss updates to the management of\n                      <jats:styled-content style=\"fixed-case\">CSCR<\/jats:styled-content>\n                      according to the risk factor modifications, pharmacological interventions,\n                      <jats:styled-content style=\"fixed-case\">PDT<\/jats:styled-content>\n                      and laser procedures and concluded that\n                      <jats:styled-content style=\"fixed-case\">PDT<\/jats:styled-content>\n                      is the current best option for\n                      <jats:styled-content style=\"fixed-case\">CSCR<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/aos.12779","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T11:40:39Z","timestamp":1435750839000},"page":"321-325","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Central serous chorioretinopathy: what we have learnt so far"],"prefix":"10.1111","volume":"94","author":[{"given":"Kah Hie","family":"Wong","sequence":"first","affiliation":[{"name":"Department of Ophthalmology LKS Faculty of Medicine The University of Hong Kong Hong Kong Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin Pong","family":"Lau","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology LKS Faculty of Medicine The University of Hong Kong Hong Kong Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[{"name":"Smt. Kanuri Santhamma Retina Vitreous Centre L. V. Prasad Eye Institute Hyderabad India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology People's Hospital Peking University and Key Laboratory of Vision Loss and Restoration Ministry of Education Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology LKS Faculty of Medicine The University of Hong Kong Hong Kong Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Y.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology LKS Faculty of Medicine The University of Hong Kong Hong Kong Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,7]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.04.008"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.09.024"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3182670fa3"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318297a07a"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12392"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2013.236"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.36"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S50407"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S54213"},{"key":"e_1_2_7_11_1","first-page":"60","article-title":"Laser treatment of central retina diseases","volume":"127","author":"Doga AV","year":"2011","journal-title":"Vestn oftalmol"},{"key":"e_1_2_7_12_1","unstructured":"Grade Definitions. U.S. Preventive Services Task Force. October (2014).http:\/\/www.uspreventiveservicestaskforce.org\/Page\/Name\/grade-definitions."},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2014.134"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2012.08.001"},{"key":"e_1_2_7_15_1","first-page":"395","article-title":"Helicobacter pylori and idiopathic central serous chorioretinopathy","volume":"134","author":"Giusti C","year":"2004","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"e_1_2_7_16_1","first-page":"189","article-title":"Eye and pregnancy","volume":"37","author":"Gotovac M","year":"2013","journal-title":"Coll Antropol"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e32833f00dc"},{"key":"e_1_2_7_18_1","first-page":"1369","article-title":"Potential involvement of mineralocorticoid receptor activation in the pathogenesis of central serous chorioretinopathy: case report","volume":"17","author":"Gruszka A","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_2_7_19_1","first-page":"1867","article-title":"Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy","volume":"7","author":"Karim SP","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.21967"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-008-0837-0"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.63.10.674"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11325-007-0112-3"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2012.02848.x"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2013.0169"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-013-3001-0"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v5.i3.355"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2012.07.004"},{"key":"e_1_2_7_29_1","first-page":"166","article-title":"Oscillatory photodynamic therapy for choroidal neovascularization and central serous retinopathy; a\u00a0pilot study","volume":"6","author":"Peyman GA","year":"2011","journal-title":"J Ophthalmic Vis Res"},{"key":"e_1_2_7_30_1","first-page":"99","article-title":"The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy","volume":"17","author":"Rahbani\u2010Nobar MB","year":"2011","journal-title":"Mol Vis"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(83)90265-9"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20130909-08"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-012-0162-3"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2010.02.005"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-4-15"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2013.824986"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI61427"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Faos.12779","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aos.12779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T21:21:34Z","timestamp":1694553694000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aos.12779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1111\/aos.12779"],"URL":"https:\/\/doi.org\/10.1111\/aos.12779","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"2014-10-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-05-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}